@oscars: Suddenly craving a big, gooey, messy burger. Film: IT TAKES TWO (1995) Directed by Andy Tennant Written by Deborah Dean Davis Starring Kirstie Alley, Steve Guttenberg, Ashley Olsen, Mary-Kate Olsen, Jane Sibbett and Philip Bosco #ItTakesTwo #AshleyOlsen #KirstieAlley #SloppyJoe #Film

The Oscars

Open In TikTok:

Region: US

Monday 06 July 2026 17:40:00 GMT

9307728

678965

3045

23693

Music

Download

No Watermark .mp4 (7.05MB) No Watermark(HD) .mp4 (9.72MB) Watermark .mp4 (6.5MB) Music .mp3

Comments

Crashleigh :

RIP Kirsty Ally. She was so talented beautiful and unique

2026-07-06 20:47:29

733

pathwise :

That scene is so ingrained in my memory, I recognised it instantly; I've always wanted to try a sloppy joe!

2026-07-06 18:30:00

43892

masr om Al donya :

why does it look goooood

2026-07-07 09:42:04

79354

kirsteen :

so it's Bolognese on a bun?

2026-07-07 01:21:07

38676

N 🪽 :

I WANNA TRY ONE NOW IM JEALOUS

2026-07-06 21:25:21

19964

⋆˚꩜｡ :

It looks delicious 😭

2026-07-07 20:08:49

585

1997s|🦢 :

احس مالح ومدهن

2026-07-21 18:44:42

286

nat :

pao com carne moída, um delícia

2026-07-08 03:12:23

1410

𑣲┆𝓥 𝐼𝒞 𝒦 𝓨 ˚.⋆ :

pensé que era arepa con carne molida 💔

2026-07-07 03:12:11

845

Дарья Сергеевна :

Только по одной булке и этому фаршу понятно что за фильм😁

2026-07-15 08:40:48

314

بدون سبب :

يشهي صراحة

2026-07-08 14:59:40

638

𝕿𝖗𝖎𝖘𝖙𝖎𝖘 𝕱𝖑𝖚𝖒𝖊𝖓 :

до сих пор мечтаю об этом бургере

2026-07-12 15:34:36

150

maria :

caramba eu soube qual era o filme só pela carne no pão

2026-07-07 23:44:57

126

aveflower :

бургеры не хотят есть бургеры,странно

2026-07-14 11:30:17

492

M❤️Л :

в детстве мечтала попробовать😁

2026-07-11 22:19:03

6282

sophiemg4783 :

I WANT ONE RIGHT NOW

2026-07-06 22:00:42

5554

Aginor :

Servia na escola municipal que eu estudava na década de 90 com o nome de buraco quente

2026-07-07 00:41:17

217

𝙰𝙹 :

Cheese on mines

2026-07-07 04:13:29

4550

Xoxolorie19 :

This & the parent trap , when Jess is making chili & the chocolate chip pancakes

2026-07-06 22:09:25

8279

Anna🥀 :

Обожала в детстве этот фильм)🍿

2026-07-14 00:24:11

96

To see more videos from user @oscars, please go to the Tikwm homepage.

Other Videos

Bình minh trên biển đà nẵng #mykhebeach #danang

Bình minh trên biển đà nẵng #mykhebeach #danang

Check Out This Fun Skeleton Lamp with Multiple Color Modes #HalloweenLamp #SkeletonDecor #LEDNightLight #SpookyDecor #CuteLamps

Check Out This Fun Skeleton Lamp with Multiple Color Modes #HalloweenLamp #SkeletonDecor #LEDNightLight #SpookyDecor #CuteLamps

Ship giúp tụi em anh ca sĩ nữa là đẹp chuẩn ọ 🤩 #GeminiHunghuynh #depma #tiemgaudepmachallenge #teana #teanahaitra @Gemini Hùng Huỳnh @Máy Nhảy VHU @TSV trường H

Ship giúp tụi em anh ca sĩ nữa là đẹp chuẩn ọ 🤩 #GeminiHunghuynh #depma #tiemgaudepmachallenge #teana #teanahaitra @Gemini Hùng Huỳnh @Máy Nhảy VHU @TSV trường H

Quần Đùi Trơn Tang Cao Su Form Trên Gối👆👆🤩#quanduitron #quanninam #xuhuongg #xuhuongtiktok #affiliate

Quần Đùi Trơn Tang Cao Su Form Trên Gối👆👆🤩#quanduitron #quanninam #xuhuongg #xuhuongtiktok #affiliate

🧬 For the first time in history, scientists are testing whether aged human cells can become younger again. Every cell in your body carries the same DNA throughout your life. What changes as you age is the epigenome the layer of chemical instructions that tells your genes when to turn on or off. Over time, these instructions drift, and cells gradually lose many of their youthful functions. This breakthrough builds on Nobel Prize-winning research by Shinya Yamanaka, who discovered that four special factors can completely reset mature cells into stem cells. While revolutionary, that approach can erase a cell’s identity, making it unsuitable for many therapeutic applications. A new investigational therapy called ER-100 takes a different path. Instead of using all four Yamanaka factors, it uses only OCT4, SOX2, and KLF4, leaving out the fourth, higher-risk factor. The goal is to partially reset the cell’s biological clock while preserving its original function. In animal studies, this approach restored aging retinal cells and improved vision, building on earlier research from David Sinclair and colleagues published in Nature (2020). On January 28, 2026, the U.S. FDA cleared ER-100 to begin its first human clinical trial. The therapy will be injected into the eye to evaluate its safety and potential effectiveness for treating optic neuropathies. This is the first partial cellular reprogramming therapy to enter human testing. While the results in animals have been promising, it is important to remember that this is an early Phase 1 clinical trial, designed primarily to assess safety. Whether it will work in humans remains unknown. If successful, this research could reshape how we think about aging not simply slowing it, but potentially restoring the function of aging cells, one cell at a time. 🔬 Science is taking another bold step forward but the real answers will come from carefully conducted human studies. 📚 Sources: Life Biosciences (FDA IND clearance, January 28, 2026); Lu et al., Nature (2020). ⚠️ Educational purposes only. This is not medical advice. ER-100 is an investigational therapy in early-stage clinical trials, and its safety and effectiveness have not yet been established. #Science #Longevity #Aging #Epigenetics #CellReprogramming

🧬 For the first time in history, scientists are testing whether aged human cells can become younger again. Every cell in your body carries the same DNA throughout your life. What changes as you age is the epigenome the layer of chemical instructions that tells your genes when to turn on or off. Over time, these instructions drift, and cells gradually lose many of their youthful functions. This breakthrough builds on Nobel Prize-winning research by Shinya Yamanaka, who discovered that four special factors can completely reset mature cells into stem cells. While revolutionary, that approach can erase a cell’s identity, making it unsuitable for many therapeutic applications. A new investigational therapy called ER-100 takes a different path. Instead of using all four Yamanaka factors, it uses only OCT4, SOX2, and KLF4, leaving out the fourth, higher-risk factor. The goal is to partially reset the cell’s biological clock while preserving its original function. In animal studies, this approach restored aging retinal cells and improved vision, building on earlier research from David Sinclair and colleagues published in Nature (2020). On January 28, 2026, the U.S. FDA cleared ER-100 to begin its first human clinical trial. The therapy will be injected into the eye to evaluate its safety and potential effectiveness for treating optic neuropathies. This is the first partial cellular reprogramming therapy to enter human testing. While the results in animals have been promising, it is important to remember that this is an early Phase 1 clinical trial, designed primarily to assess safety. Whether it will work in humans remains unknown. If successful, this research could reshape how we think about aging not simply slowing it, but potentially restoring the function of aging cells, one cell at a time. 🔬 Science is taking another bold step forward but the real answers will come from carefully conducted human studies. 📚 Sources: Life Biosciences (FDA IND clearance, January 28, 2026); Lu et al., Nature (2020). ⚠️ Educational purposes only. This is not medical advice. ER-100 is an investigational therapy in early-stage clinical trials, and its safety and effectiveness have not yet been established. #Science #Longevity #Aging #Epigenetics #CellReprogramming

About

Robot
API

Legal

Privacy Policy